Next-Gen Psychedelics for Mental Health

This chapter explores the innovative development of next-generation psychedelic compounds for treating mental health conditions, highlighting their potential benefits over traditional treatments. It discusses specific compounds like 5-MU benzoate and BPL03, their mechanisms of action, and the promising results from early clinical trials. The conversation emphasizes the importance of regulatory pathways, health economics, and accessibility in the context of modern psychiatry.